Integra LifeSciences
IART
IART
257 hedge funds and large institutions have $4.67B invested in Integra LifeSciences in 2018 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 83 increasing their positions, 88 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
6% less repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 88
7.46% less ownership
Funds ownership: 90.04% → 82.58% (-7.5%)
Holders
257
Holding in Top 10
3
Calls
$3.1M
Puts
$1.51M
Top Buyers
| 1 | +$75.1M | |
| 2 | +$46.3M | |
| 3 | +$36.9M | |
| 4 |
ClearBridge Investments
New York
|
+$24.2M |
| 5 |
D.E. Shaw & Co
New York
|
+$24.1M |
Top Sellers
| 1 | -$126M | |
| 2 | -$36.2M | |
| 3 | -$23.1M | |
| 4 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$20.5M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$17.1M |